Loading...
Asston Pharmaceuticals Limited IPO Details – Price, Date, GMP & Analysis
Listed
SME
Price Range:
Rs.123.00
Issue Size:
Rs.27.56 Cr
Lot Size:
1000 shares
Open Date:
July 9
Asston Pharmaceuticals Limited IPO Overview
Bidding Dates
July 9 - July 11
Min Investment
₹123,000
Price Range
₹123.00
Issue Size
₹27.56 Cr
IPO DRHP Doc
Company Overview
Asston Pharmaceuticals Limited, incorporated in 2019, specializes in exporting healthcare products globally. It offers a diverse range of pharmaceuticals, including tablets, capsules, sachets, and syrups across various therapeutic categories. The company manufactures products for direct sales and contract manufacturing, adhering to high-quality standards with FDA certification and NQA accreditation. As of September 30, 2024, it employs 46 permanent and 6 contractual employees.
IPO Timeline
Opens
Jul 9
Closes
Jul 11
Allotment
Jul 14
Refunds
Jul 15
Shares Credit
Jul 15
Listing
Jul 16
Opens
Jul 9
Closes
Jul 11
Allotment
Jul 14
Refunds
Jul 15
Shares Credit
Jul 15
Listing
Jul 16
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 85.76x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 353.14x | Oversubscribed |
| RII (Retail Individual Investors) | 172.06x | Oversubscribed |
| Total Subscription | 186.55x | Oversubscribed |
Last updated: Jul 11, 2025, 05:06 PM
Current GMP:
Rs.26
Est. Listing:
Rs.149
Est. Gain:
+21.1%
Star Rating:
★★★★★(4/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ₹28.12 Cr | ₹28.12 Cr | ₹20.26 Cr | ₹13.69 Cr |
| EBITDA | ₹6.16 Cr | ₹6.16 Cr | ₹2.55 Cr | ₹1.52 Cr |
| Net Worth | ₹10.72 Cr | ₹10.72 Cr | ₹6.39 Cr | ₹1.99 Cr |
| Profit After Tax | ₹4.33 Cr | ₹4.33 Cr | ₹1.36 Cr | ₹1.06 Cr |
| Reserves and Surplus | ₹4.45 Cr | ₹4.45 Cr | ₹5.61 Cr | ₹1.29 Cr |
| Revenue | ₹25.61 Cr | ₹25.61 Cr | ₹15.84 Cr | ₹7.19 Cr |
| Total Borrowing | ₹7.26 Cr | ₹7.26 Cr | ₹6.82 Cr | ₹5.25 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Promoters with 30+ years’ global pharma experience drive brand and compliance.
- Diverse product portfolio across dosage forms strengthens global market adaptability.
- Facilities strategically located near ports and airports, enabling efficient global exports.
- Skilled workforce ensures quality compliance across outsourced manufacturing and distribution.
- Strong relationships with WHO-GMP certified contract manufacturers ensure quality compliance.
- Outsourced manufacturing enables asset-light operations with minimal regulatory or capex risks.
IPO Details
Asston Pharmaceuticals IPO Details
| Face Value | ₹10 per share |
| IPO Date | July 9, 2025 to July 11, 2025 |
| Issue Price | ₹123 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | July 16, 2025 |
| Lot Size | 1,000 Shares |
| Net Offered to Public | 21,28,000 shares (aggregating up to ₹26.17 Cr) |
| Sale Type | Fresh Capital |
| Share Holding Post Issue | 85,12,360 shares |
| Share Holding Pre Issue | 62,71,360 shares |
| Total Issue Size | 22,41,000 shares (aggregating up to ₹27.56 Cr) |
Asston Pharmaceuticals IPO Reservation
Share Reservation Distribution
QIB
1,060,000 shares (66%)
Retail
746,000 shares (46.45%)
Anchor Investors
635,000 shares (39.54%)
QIB (Ex-Anchor)
425,000 shares (26.46%)
HNI (NII)
322,000 shares (20.05%)
bNII (>₹10L)
215,000 shares (13.39%)
Market Maker
113,000 shares (7.04%)
sNII (<₹10L)
107,000 shares (6.66%)
Asston Pharmaceuticals IPO Promoter Holding
| Share Holding Post Issue | 50.66% |
| Share Holding Pre Issue | 68.76% |
Asston Pharmaceuticals IPO Listing Details
| ₹123 per share |
| 544445 |
| INE0SJX01015 |
| July 16, 2025 |
| MT |
Key Dates
Open Date:July 9
Close Date:July 11
Listing Date:July 16
